---
schema_version: "secwatch.filing_event.v1"
accession: "0001185185-23-000770"
form_type: "8-K"
ticker: "STEX"
cik: "0001530766"
company_name: "Streamex Corp."
filed_at: "2023-07-31T23:59:59+00:00"
generated_at: "2026-06-12T21:58:16.120565+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# BioSig Technologies raises $1.5M in PIPE with share and warrant sale

## Summary
- Sold 1,467,624 shares at $1.02206/share and warrants for 733,812 shares at $0.95956.
- Gross proceeds of $1,499,999.79 from accredited investor.
- Laidlaw & Company received warrant for 110,072 shares as compensation.
- Warrants exercisable after 6 months, expire 5.5 years from issuance.
- Securities sold under Section 4(a)(2) and Regulation D, unregistered.

## SEC filing metadata
- accession: 0001185185-23-000770
- form_type: 8-K
- ticker: STEX
- cik: 0001530766
- company_name: Streamex Corp.
- filed_at: 2023-07-31T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1530766/000118518523000770/0001185185-23-000770-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1530766/000118518523000770/biosig20230728_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001185185-23-000770
- JSON: https://secwatch.observer/filing/0001185185-23-000770.json
- Plain text: https://secwatch.observer/filing/0001185185-23-000770.txt

## Key facts
- Material Agreements
  Streamex Corp. entered into Securities Purchase Agreement with a certain accredited investor valued at $1,499,999.79 (effective 2023-07-31).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: a certain accredited investor
  - Value: $1,499,999.79
  - Effective: 2023-07-31
  source text: On July 31, 2023, BioSig Technologies, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with a certain accredited investor (the “Investor”), pursuant to which the Company sold to the Investor an aggregate of 1,467,624 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”) at a purchase price of $1.02206 per share, and a warrant (the “Warrant”) to purchase up to 733,812 shares of Common Stock (the “Warrant Shares” and together with the Shares and the Warrant, the “Securities”), at an exercise price of $0.95956 per share, that will become exercisable six months after the date of issuance and will expire five and one-half years following the date of issuance, in exchange for aggregate consideration of $1,499,999.79 (the “July PIPE”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1530766/000118518523000770/0001185185-23-000770-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
